arrow
罗慧 封面图

罗慧 (Hui Luo)

中山大学肿瘤防治中心工作邮箱:luohy@sysucc.org.cn
H指数:58
被引数:1.4万

个人简介

"2008年本科毕业于湖南师范大学生命科学学院,2013年于北京协和医学院获得博士学位,2013年-2016年在深圳大学当任讲师,2016年-至今在中山大学附属第五医院工作。\n发表论文/著作\n(1) Hailing Yu;# Yongquan Huang#; Zeyu Cai; Kaichen Huang; Ting Yu; Huimin Lan; Qianqian Zhang; Lili Wu*; Hui Luo* ; Tumor Microenvironment-Sensitive Ca2+ Nanomodulator Combined with the Sonodynamic Process for Enhanced Cancer Therapy, ACS Apllied Materials&Interfaces, 2024, 16(7): 8275-8288. (2) Hui Luo#; Yongquan Huang#; Zeyu Cai; Kaichen Huang; Ting Yu; Huimin Lan; Qianqian Zhang; Lili Wu*; Hailing Yu* ; Synergistic approach to combat triple-negative breast cancer: Ti3C2/TiO2- based photothermal therapy combined with sonodynamic effect for tumor ablation, Ceramics International, 2024, 50(4): 6042-6054. (3) Hailing Yu #, Yongquan Huang#,, Zhisheng Nong#, Xi Lin, Kexin Tang, Zeyu Cai, Kaichen Huang, Ting Yu, Huimin Lan, Qianqian Zhang, Qiang Wang, Lei Yang, Jingchuan Zhu, Lili Wu*, Hui Luo*. In-Situ Grown Nanocrystal TiO2 on 2D Ti3C2 Nanosheets with Anti-Tumor Activity from Photo-Sonodynamic Treatment and Immunology. International Journal of Nanomedicine 2024:19 7963–7981. (4) Hailing Yu#; Kexin Tang#; Zeyu Cai; Xi Lin; Yongquan Huang; Ting Yu; Qianqian Zhang; Qiang Wang; Lili Wu; Lei Yang; Hong Shan*; Hui Luo* ; Carbon Dots-Based Nanozyme for Drug-Resistant Lung Cancer Therapy by Encapsulated Doxorubicin/siRNA Cocktail, International Journal of Nanomedicine, 2023, 18(/): 933-948."

教育背景

  • 2008.12

    湖南师范大学生命科学学院 本科

  • 2013.12

    北京协和医学院 博士学位

工作经历

  • 2016.01 – 至今

    中山大学附属第五医院

    工作

  • 2013.01 – 2016.12

    深圳大学

    讲师

荣誉奖项

暂无内容

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma, with or without peritoneal metastases: a post-hoc analysis on RATIONALE-305 study

替雷利珠单抗联合化疗与安慰剂联合化疗作为治疗伴有或不伴有腹膜转移的晚期胃或胃食管结合部腺癌患者的一线治疗方案:RATIONALE-305研究的回顾性分析

2026-05-150
OAAI
UNC13D c.2588G>A Nucleotide Variant Impairs NK-Cell Cytotoxicity in Adult-Onset EBV-Associated Hemophagocytic Lymphohistiocytosis: A Pedigree Study

Gu J, An N, Wang X, Xiao M, and Luo H. UNC13D c.2588G>A核苷酸变异损害成人EBV相关噬血淋巴组织细胞增生症的NK细胞细胞毒性:一项家系研究。国际分子科学杂志。(2025) 26。doi: 10.3390/ijms26178683

2026-03-030
OAAI
The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNA

INSPECTOR研究:基于酶辅助高信噪比测序甲基化循环肿瘤DNA的多癌种早期检测方法的临床转化可行性提升

2025-10-300
OAAI
Alistipes finegoldii augments the efficacy of immunotherapy against solid tumors

Alistipes finegoldii 增强了针对实体瘤的免疫疗法效果

2025-07-240
PRE
Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer

将SHR-1701添加到一线卡培他滨和奥沙利铂(XELOX)联合贝伐珠单抗中用于不可切除的转移性结直肠癌

2024-12-160
OAAI